Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Solta Medical, Inc. Stockholders
2013年12月17日 - 6:54AM
ビジネスワイヤ(英語)
Kirby McInerney LLP is investigating potential claims against
the Board of Directors of Solta Medical, Inc. (“Solta” or the
“Company”) (NASDAQ:SLTM) concerning the proposed acquisition of the
Company by Valeant Pharmaceuticals International, Inc. (“Valeant”)
(NYSE:VRX). Under the terms of the definitive merger agreement,
Solta stockholders will receive $2.92 in cash for each share of
Solta owned, valuing the transaction at approximately $250
million.
The investigation concerns whether the Solta Board of Directors
violated its fiduciary duties by agreeing to the proposed
transaction and whether the $2.92 per share proposed consideration
adequately values Solta’s common stock.
If you are a Solta stockholder and wish to obtain additional
information, please contact J. Brandon Walker, Esq. by email
at bwalker@kmllp.com, by telephone at (212) 699-1145 or (888)
529-4787, or by filling out this contact form. There is no cost or
obligation to you.
Kirby McInerney LLP is a New York-based law firm concentrating
in securities, shareholder, whistleblower, antitrust and consumer
litigation. For additional information, please go to
www.kmllp.com.
Kirby McInerney LLPJ. Brandon Walker, Esq.,
212-699-1145888-529-4787bwalker@kmllp.com
Solta Medical, (MM) (NASDAQ:SLTM)
過去 株価チャート
から 5 2024 まで 6 2024
Solta Medical, (MM) (NASDAQ:SLTM)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Solta Medical, (MM) (ナスダック市場): 0 recent articles
その他のSolta Medical, (MM)ニュース記事